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Abstract
Introduction: Chronic relapsing inflammatory optic neuropathy is a recently described form of recurrent isolated
subacute optic neuropathy. The condition is highly responsive to systemic steroid treatment and prone to relapse
on steroid withdrawal. A complete work up for demyelination, autoimmune disease and sarcoidosis must be made
before considering chronic relapsing inflammatory optic neuropathy.
Case presentation: We describe the case of a 52-year-old Caucasian woman who presented with isolated
subacute optic neuropathy. There was no evidence of demyelination, autoimmunity or sarcoidosis. There was an
abrupt and prompt response to systemic corticosteroids and a relapse of the condition on steroid withdrawal.
Conclusions: Chronic relapsing inflammatory optic neuropathy requires careful consideration and differentiation
from demyelinating optic neuritis and ischemic optic neuropathy since the treatment is different and the outcome
without treatment is likely to be poor. The importance of identifying these patients has considerable clinical
implications as the condition is highly responsive to steroids.
Introduction
Chronic relapsing inflammatory optic neuropathy
(CRION) is a recently described form of recurrent iso-
lated optic neuropathy. The condition comprises a char-
acteristic clinical syndrome of subacute optic
neuropathy with prominent pain in which there is a
clear and prompt response to treatment with systemic
steroids but a relapse on steroid withdrawal [1]. The
condition does not exhibit any evidence of additional
neurological deficits, sarcoidosis or systemic autoim-
mune diseases. Kidd et al. in their report of 15 patients
described a clinical syndrome of unilateral or bilateral
optic neuropathy characterized by pain followed by sub-
acute visual loss in keeping with an inflammatory cause
[1]. Treatment with corticosteroids induced abrupt relief
of pain and restoration of visual acuity. Following ster-
oid withdrawal patients tended to relapse, warranting in
most cases long term immunosuppression.
Case presentation
A 52-year-old Caucasian woman with a past medical
history of severe hypertension and non-insulin depen-
dent diabetes mellitus presented with bilateral subacute
visual loss which progressed over eight to 10 days to
perceiving only light in the left eye and only hand move-
ments in the right eye. The visual loss was preceded by
dull ocular pain which persisted after the onset of visual
loss. The patient experienced pain on eye movements
but had no double vision. The patient did not have any
temporal artery tenderness and temporal pulses were
palpable bilaterally.
On fundoscopic examination, both optic discs were
swollen and no retinopathic changes of diabetes or
hypertension were evident. There was no evidence of
venous engorgement. There was reduced color vision in
both eyes and a left relative afferent papillary defect was
present. Visual field mapping showed a left central sco-
toma and a normal right sided visual field. The patient’s
blood pressure was 152/80 on admission and lower on
subsequent readings during her hospital stay. The
remaining neurological examination was unremarkable.
There was nothing in her history or physical
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examination suggestive of connective tissue disease or
sarcoidosis. Initial blood tests showed a normal full
blood count, normal urea and electrolytes (U&Es), nor-
mal liver function tests, a normal C-reactive protein
(CRP; < 1) and plasma viscosity and a raised glycated
haemoglobin (HbA1c) of 7.3% (normal 4 to 6.1). Chest
X-ray was normal. A lumbar puncture was performed
which yielded cerebrospinal fluid (CSF) with normal
white and red blood cells, a normal angiotension con-
verting enzyme (ACE) level, no oligoclonal bands and a
marginally elevated protein level of 467.7 mg/L (normal
150 to 450 mg/L). A magnetic resonance imaging (MRI)
scan of her brain and spinal cord was normal.
A provisional diagnosis of acute ischaemic optic neu-
ropathy was made by the general medical team and the
patient was started on aspirin with omeprazole cover.
On review by the neurology team a day later the cause
was thought to be inflammatory rather than ischemic.
She received a three day course of intravenous methyl
prednisolone. Vision improved to 6/6 in both eyes
within two days with full restoration of color vision and
visual field defects. Ten days later however, vision dete-
riorated again in the right eye to 6/36 with a temporal
peripheral field loss. The relative afferent papillary defect
had now switched to the right eye. The patient received
500 mg oral methyl prednisolone for five days. Her
visual acuity and visual fields returned to normal within
two days.
A subsequent auto-immunity screen including aqua-
porin-4 antibodies was negative. Visual evoked poten-
tials performed twelve days after the onset of the second
episode of visual loss were delayed bilaterally (left >
right) indicating bilateral optic nerve dysfunction. Her
pattern electroretinograms, brainstem evoked potentials,
median nerve and posterior tibial somatosensory evoked
potentials were normal bilaterally.
There was no evidence of Leber’s hereditary optic
neuropathy on genetic molecular analysis. The
m.11778G > A, m.3460G > A, m.14484T > C mitochon-
drial mutations were tested for and not detected in our
patient.
A chest computed tomography (CT) was normal and
did not show any hilar adenopathy or any other features
of sarcoidosis.
Serial MRIs over the next four months were normal
without any inflammatory lesions and oligoclonal bands
were negative which excluded multiple sclerosis.
Discussion
Our patient presented with subacute visual loss, the
general medical team made a provisional diagnosis of
acute ischemic optic neuropathy. When reviewed by the
neurology team the pathology was deemed to be optic
neuritis, however there was no evidence for any
demeyelinating or autoimmune process. Sarcoidosis was
also ruled out.
There was an excellent and prompt response to corti-
costeroids and a dramatic deterioration of vision follow-
ing steroid withdrawal consistent with CRION. Our case
report highlights the importance of the prompt recogni-
tion of CRION. The condition is an extremely rare
cause of visual loss caused by optic neuropathy and if
missed it can have sinister consequences such as perma-
nent visual loss.
Conclusion
The clinical picture of the patient was similar to those
described by Kidd et al. in terms of subacute onset of
visual deficit, significant pain, excellent response to ster-
oids and visual deterioration following steroid withdra-
wal [1]. The importance of identifying these patients has
considerable clinical implications as the condition is
highly responsive to steroids. CRION requires careful
consideration and differentiation from demyelinating
optic neuritis and ischemic optic neuropathy since the
treatment is entirely different and the outcome without
treatment is likely to be poor. A complete work up for
demyelination, autoimmune disease and sarcoidosis
must be made before considering CRION. At present
there are no systemic studies evaluating the duration
and intensity of immunosuppression required in patients
with CRION [2].
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